Victory Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.9M | Buy |
564,790
+11,940
| +2% | +$167K | 0.01% | 1179 |
|
|
2025
Q1 | $7.45M | Buy |
552,850
+142,410
| +35% | +$1.92M | 0.01% | 1156 |
|
|
2024
Q4 | $7.87M | Buy |
+410,440
| New | +$7.87M | 0.01% | 1150 |
|
|
2020
Q2 | – | Sell |
-1,025
| Closed | -$6K | – | 3282 |
|
|
2020
Q1 | $6K | Buy |
+1,025
| New | +$6K | ﹤0.01% | 3449 |
|
|
2019
Q4 | – | Sell |
-264
| Closed | -$3K | – | 3275 |
|
|
2019
Q3 | $3K | Buy |
+264
| New | +$3K | ﹤0.01% | 3580 |
|